Genetic study of ICAM1 in clinical malaria in Senegal

R Ndiaye1, A Sakuntabhai, I Casadémont

  • 1Génétique des Maladies Infectieuses et Autoimmunes, Institut Pasteur, 28 rue du Docteur Roux, 75724 Paris cedex 15, France.

Tissue Antigens
|April 28, 2005
PubMed

Insights

This study investigated the intercellular adhesion molecule 1 (ICAM1) gene's role in severe malaria risk. Genetic analysis in Senegalese villages found no evidence that ICAM1 variants influence malaria susceptibility or severity.

Area of Science:

  • Genetics
  • Immunology
  • Infectious Diseases

Background:

  • Severe malaria risk is linked to numerous genes, but findings for intercellular adhesion molecule 1 (ICAM1) variants are conflicting.
  • In vitro studies suggest a functional role for the ICAM1(Kilifi) variant in malaria, yet in vivo evidence remains unclear.

Purpose of the Study:

  • To investigate the implication of ICAM1 genetic variability in malaria susceptibility and resistance.
  • To understand the clinical relevance of ICAM1 in malaria pathogenesis, focusing on parasite density and attack frequency.

Main Methods:

  • Conducted linkage and association studies of the full ICAM1 genetic variability.
  • Analyzed ICAM1 variants against clinical malaria phenotypes in two endemic Senegalese villages.

Main Results:

  • No statistical evidence was found linking ICAM1 genetic variability to malaria phenotypes.
  • The study did not support a role for ICAM1 in determining parasite density or the number of malaria attacks.

Conclusions:

  • ICAM1 genetic variations do not appear to play a significant role in the studied malaria phenotypes in this population.
  • Further research may be needed to fully elucidate the complex genetic underpinnings of malaria susceptibility.